Please login to the form below

infectious diseases

This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.

WHO launches funding appeal for greater Horn of Africa prompted by food crisis

WHO is looking to the international community to support our work on the ground responding to this dual threat, providing treatment for malnourished people, and defending them against infectious diseases.”.

Latest news

Fauci addresses need for pan-coronavirus and intranasal vaccines to combat COVID-19 variants

The National Institute of Allergy and Infectious Diseases (NIAID) director specifically detailed the call for pan-coronavirus candidates and mucosal options that can be given to patients intranasally, all the while
Evotech, Boehringer Ingelheim and bioMérieux launch joint venture to combat antimicrobial resistance

The collaboration will unite Evotec’s expertise on infectious disease research, bioMérieux’s expertise in infectious disease diagnostics and Boehringer Ingelheim’s broad drug discovery and significant clinical development capabilities.
New Pfizer initiative, ‘An Accord for a Healthier World’, launched to improve global health equity

This is how all global problems should be tackled.”. The company has also pledged to provide 23 medicines and vaccines to treat infectious diseases, certain cancers and rare and inflammatory diseases. ... These diseases result in almost one million
AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster

Vaxzevria is a ‘viral vector’ vaccine, a technology that is also used to create vaccines for other infectious diseases like flu, HIV and Ebola. ... This technology has been used by scientists for the past 40 years to fight other infectious diseases
Shionogi and F2G partner to develop antifungal treatment olorofim

Infectious Disease Product (QIDP) designation. ... Isao Teshirogi, CEO of Shionogi, said: “We will continue to address unmet medical needs in infectious diseases and work towards total care for this area.

More from news
Approximately 6 fully matching, plus 263 partially matching documents found.

Latest Intelligence

Paving the way for representation in clinical trials

EM-90081 March 2022. Lee-Ann Farrell is Vaccines Lead and Dr Mohamed Lockhat is Medical Director, Infectious Diseases and Vaccines, both at Janssen UK. . ... Lee-Ann Farrell is Vaccines Lead and Dr Mohamed Lockhat is Medical Director, Infectious Diseases
A new era for UK-Japanese scientific research relations

In 1961, it established universal health insurance, it made huge advancements in the control and eradication of infectious diseases and, notably, it achieved the world’s highest life expectancy. ... Japan’s health system is seeing a corresponding
The pandemic preparedness paradox

There is no market for sporadic infectious diseases. Even the use of the word ‘market’ is incorrect. ... And we know how to translate academic inventions into medicines that can help patients, but today that’s not happening, because there is no
The search for effective drug treatments for COVID-19

medicine. to contribute to the medical response in public health emergencies. The EUA was based on then available data from two global clinical trials – the National Institute for Allergy and Infectious ... Diseases’ (NIAID) placebo-controlled phase
As COVID-19 takes over the world, biopharma fights back

I don’t think the ongoing trials will tell us a lot,” said H Clifford Lane, clinical director at the National Institutes of Allergy and Infectious Diseases (NIAID). ... IL-6 is a type of cytokine that plays an important role in immune response and is

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest appointments

Evoke KYNE promotes Dante DelVecchio to senior VP

In his new role, he will become a member of the firm’s senior management team, and will continue to oversee key client engagements in infectious diseases, vaccines and immuno-oncology.
$New faces at HCA, P\S\L Group and Health Unlimited$ New faces at HCA, P\S\L Group and Health Unlimited

Over her 15-year career, Peck has worked across a range of healthcare communications areas, including oncology, dermatology, infectious diseases and more.
New hires at Bayer, Eisai and Accord Healthcare

Most recently, she held the position of vice president of M&A operations and divestitures and led the infectious diseases and vaccines business development. ... She joins Eisai from Merck, where she served as executive director, clinical quality assurance
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

and infectious diseases.
Nabriva Therapeutics appoints chief medical officer

Commenting on the appointment, Dr Colin Broom, chief executive officer of Nabriva, said: “Jennifer has broad expertise in infectious diseases and internal medicine with extensive experience in both clinical development and

More from appointments
Approximately 0 fully matching, plus 38 partially matching documents found.

Latest from PMHub

Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide.
Improving healthcare for rare disease patients

4. but there are also rare infectious diseases, rare forms of cancer and more. ... Joszt L. Not So Rare: 300 Million People Worldwide Affected by Rare Diseases.
Wearable Technologies for Detecting Pre-Symptomatic Illness and Infections

Tejaswini Mishra, Research Scientist at Stanford University School of Medicine, dives into her research on using wearable technologies for detecting COVID-19 and other diseases before patients become symptomatic. ... Among other things, she discusses
Understanding COVID-19 and varying responses across the globe

The Coalition for Epidemic Preparedness Innovation (CEPI), a global alliance financing and coordinating the development of vaccines against emerging infectious diseases, launched in 2017 and is needed now more than ever. ... These three factors all aid
Lucid Group adds more magic to the mix with four new hires

Betty has worked on a wide variety of medical education initiatives in various therapeutic areas including immuno-oncology, infectious diseases, transplantation and multiple sclerosis. ... Katherine has a background in oncology, neurology, metabolic